Microbio

4128.TWO

0.64 USD

-0.01

-1.54%

Overview

Last close

0.64 usd

Market cap

373.57M usd

52 week high

1.36 usd

52 week low

0.61 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

6.4537

Price/Book Value

1.3243

Enterprise Value

320.25M usd

EV/Revenue

5.3717

EV/EBITDA

-10.9139

Key financials

Revenue TTM

59.62M usd

Gross Profit TTM

23.35M usd

EBITDA TTM

-9.50M usd

Earnings per Share

-0.06 usd

Dividend

N/A usd

Total assets

407.95M usd

Net debt

N/A usd

About

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei City, Taiwan.